Annual Operating Profit
-$18.50 M
-$942.10 K-5.37%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual operating income is -$18.50 million, with the most recent change of -$942.10 thousand (-5.37%) on December 1, 2023.
- During the last 3 years, RNAZ annual operating profit has fallen by -$17.77 million (-2445.49%).
- RNAZ annual operating profit is now -3948.04% below its all-time high of -$456.90 thousand, reached on December 31, 2019.
Performance
RNAZ Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$2.15 M
+$2.96 M+57.89%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly operating income is -$2.15 million, with the most recent change of +$2.96 million (+57.89%) on September 1, 2024.
- Over the past year, RNAZ quarterly operating profit has increased by +$3.13 million (+59.24%).
- RNAZ quarterly operating profit is now -12951.52% below its all-time high of -$16.50 thousand, reached on March 1, 2020.
Performance
RNAZ Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$14.60 M
+$3.13 M+17.65%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ TTM operating income is -$14.60 million, with the most recent change of +$3.13 million (+17.65%) on September 1, 2024.
- Over the past year, RNAZ TTM operating profit has increased by +$4.94 million (+25.27%).
- RNAZ TTM operating profit is now -88382.42% below its all-time high of -$16.50 thousand, reached on March 1, 2020.
Performance
RNAZ TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RNAZ Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.4% | +59.2% | +25.3% |
| 3 y3 years | -2445.5% | +7.5% | -322.5% |
| 5 y5 years | -3948.0% | -10000.0% | -10000.0% |
RNAZ Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -214.9% | at low | at high | +59.2% | -148.6% | +25.3% |
| 5 y | 5-year | -3948.0% | at low | <-9999.0% | +59.2% | <-9999.0% | +25.3% |
| alltime | all time | -3948.0% | at low | <-9999.0% | +59.2% | <-9999.0% | +25.3% |
TransCode Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.15 M(-57.9%) | -$14.60 M(-17.7%) |
| Jun 2024 | - | -$5.11 M(+56.8%) | -$17.73 M(+4.6%) |
| Mar 2024 | - | -$3.26 M(-19.9%) | -$16.95 M(-8.4%) |
| Dec 2023 | -$18.50 M(+5.4%) | -$4.07 M(-23.0%) | -$18.50 M(-5.3%) |
| Sep 2023 | - | -$5.28 M(+21.9%) | -$19.54 M(+5.3%) |
| Jun 2023 | - | -$4.33 M(-9.9%) | -$18.55 M(-1.8%) |
| Mar 2023 | - | -$4.81 M(-5.9%) | -$18.89 M(+7.6%) |
| Dec 2022 | -$17.55 M | -$5.11 M(+18.9%) | -$17.55 M(+15.2%) |
| Sep 2022 | - | -$4.30 M(-8.0%) | -$15.24 M(+14.9%) |
| Jun 2022 | - | -$4.67 M(+34.6%) | -$13.27 M(+49.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.47 M(+24.1%) | -$8.89 M(+51.4%) |
| Dec 2021 | -$5.87 M(+708.3%) | -$2.80 M(+20.1%) | -$5.87 M(+70.0%) |
| Sep 2021 | - | -$2.33 M(+680.0%) | -$3.46 M(+152.9%) |
| Jun 2021 | - | -$298.50 K(-33.6%) | -$1.37 M(+17.8%) |
| Mar 2021 | - | -$449.50 K(+18.6%) | -$1.16 M(+59.6%) |
| Dec 2020 | -$726.60 K(+59.0%) | - | - |
| Dec 2020 | - | -$379.00 K(+58.2%) | -$726.60 K(+109.0%) |
| Sep 2020 | - | -$239.50 K(+161.5%) | -$347.60 K(+221.6%) |
| Jun 2020 | - | -$91.60 K(+455.2%) | -$108.10 K(+555.2%) |
| Mar 2020 | - | -$16.50 K | -$16.50 K |
| Dec 2019 | -$456.90 K | - | - |
FAQ
- What is TransCode Therapeutics annual operating income?
- What is the all time high annual operating profit for TransCode Therapeutics?
- What is TransCode Therapeutics annual operating profit year-on-year change?
- What is TransCode Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly operating profit year-on-year change?
- What is TransCode Therapeutics TTM operating income?
- What is the all time high TTM operating profit for TransCode Therapeutics?
- What is TransCode Therapeutics TTM operating profit year-on-year change?
What is TransCode Therapeutics annual operating income?
The current annual operating profit of RNAZ is -$18.50 M
What is the all time high annual operating profit for TransCode Therapeutics?
TransCode Therapeutics all-time high annual operating income is -$456.90 K
What is TransCode Therapeutics annual operating profit year-on-year change?
Over the past year, RNAZ annual operating income has changed by -$942.10 K (-5.37%)
What is TransCode Therapeutics quarterly operating income?
The current quarterly operating profit of RNAZ is -$2.15 M
What is the all time high quarterly operating profit for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly operating income is -$16.50 K
What is TransCode Therapeutics quarterly operating profit year-on-year change?
Over the past year, RNAZ quarterly operating income has changed by +$3.13 M (+59.24%)
What is TransCode Therapeutics TTM operating income?
The current TTM operating profit of RNAZ is -$14.60 M
What is the all time high TTM operating profit for TransCode Therapeutics?
TransCode Therapeutics all-time high TTM operating income is -$16.50 K
What is TransCode Therapeutics TTM operating profit year-on-year change?
Over the past year, RNAZ TTM operating income has changed by +$4.94 M (+25.27%)